TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2014

Randomized phase III trial of temsirolimus and bevacizumab versus interferon alfa and bevacizumab in metastatic renal cell carcinoma: INTORACT trial.

Brian I Rini et al.PubMed ↗Publisher ↗

No numbers read from the abstract.